[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100426835":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":38,"collaborators":10,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":10,"eligibilityCriteria":46,"healthyVolunteers":47,"sex":48,"minAge":10,"maxAge":10,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Quell Therapeutics Limited","INDUSTRY",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Specimen collection to support development of engineering Treg",null,[12],"Other: White blood cell and blood collection",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"OTHER","White blood cell and blood collection","Mononucleocytes will be collected via apheresis",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Gareth Wright","CONTACT","+4(0)2070969012","contact@quell-tx.com",[26],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":10},"Quell Investigator Site 01","RECRUITING","London","United Kingdom","UK",{"type":33,"coordinates":34},"Point",[35,36],-0.12574,51.50853,{"lat":36,"lon":35},{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100426835","prospective-study-of-white-blood-cells-100426835",false,"NCT04838171","Prospective Study of White Blood Cells","Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies","No additional inclusion\u002F exclusion criteria will be applied by Quell other than those specified by the consenting institutions.",true,"ALL",{"count":50,"type":51},10,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.",[55,56,57],"Autoimmune Diseases","Inflammation","Rejection; Transplant, Liver","2026-01-16",{"date":60,"type":61},"2026-01-21","ACTUAL",{"date":63,"type":61},"2021-03-24",{"date":65,"type":51},"2030-01",{"name":5,"class":6},1]